You have 9 free searches left this month | for more free features.

Condition

Disorders of Sphingolipid Metabolism (Healthy Volunteers) (1)

Gaucher's Disease Type III (1)

Polycystic Kidney, Autosomal Dominant (1)

Overall Status

Completed (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Genzyme, a Sanofi Company (3)

Collaborator

Intervention

venglustat (3)

imiglucerase (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

venglustat

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Disorders of Sphingolipid Metabolism (Healthy Volunteers) Trial in Nottingham (venglustat)

Completed

Disorders of Sphingolipid Metabolism (Healthy Volunteers)

venglustat

Nottingham, Nottinghamshire, United Kingdom

Investigational Site Number :8260001

Mar 8, 2022

Gaucher's Disease Type III Trial in Fairfax, Beijing, Guangzhou (Venglustat, imiglucerase)

Recruiting

Gaucher's Disease Type III

Venglustat
imiglucerase

New Haven, Connecticut
+13 more

Jan 13, 2023

Polycystic Kidney, Autosomal Dominant Trial in Worldwide (Venglustat GZ402671, Placebo)

Terminated

Has Results

Polycystic Kidney, Autosomal Dominant

Venglustat
Placebo

Birmingham, Alabama
+94 more

Feb 1, 2023